Simple convenience in every application

On the spot analysis for rapid, confident decisions

Make rapid, confident decisions in applications throughout protein research, cell line development and biotherapeutic process development; the Amperia system quantifies biologics, AAVs and a variety of other proteins at-line for immediate answers.

Why wait for complex centralised equipment when you simply need titre data?

The Amperia system’s flexibility and effortless automation help to relieve analytical delays and accelerate bioprocessing workflows.

Whether you are identifying stable high producing clones, driving bioprocess innovation or optimising process development for viral-vector production, the Amperia provides operational efficiency by combining accurate automated quantification with the convenience of near real-time data. Remove the need to store samples or outsource analysis to other teams, focus on executing improvements and delivering impact in your work.

Amperia instrument for rapid titre data

Learn more about our applications

antibody quantification

Antibody Quantification

Quantify antibodies from crude samples using an affordable platform that can easily be placed at line. Measurements take as little as 1 minute per sample. Optimise the assessment of your transient expression, accelerate your cell line development programme, or gain access to at-line titre readings right next to your bioreactor. The compact size means the Amperia can be operated anywhere, whether it is within a laminar flow cabinet or on a tight lab bench.
Learn more
aav quantification

AAV Quantification

Quantifying the physical titre of viral vectors in bioprocessing is crucial for process optimisation and maintaining consistency, efficacy, and safety of products such as gene therapies. Accurate measurement ensures uniformity between batches, and optimises resource utilisation, streamlining the development process. The Amperia enables users to automate capsid ELISAs and capture physical titre at-line in real time. This improves data accuracy by relieving manual processing and eliminates analytical bottlenecks that can be caused by the need for central analytical support.
Learn more
{

Amperia allowed us to rapidly screen 120 IgG-producing CHO mini-pool populations. The Amperia system saved us at least two weeks of work that would normally be spent on manual ELISA.

We see the Amperia providing a huge benefit to researchers involved in cell line development who want accurate results quickly.

Professor Alan Dickson

Study Lead, Centre of Excellence in Biopharmaceuticals, University of Manchester
{

The best technologies in the world are of little use, if they are not affordable and simple to use.

With RED, we have the technology to build instruments like Amperia that are affordable and simple, without compromising on performance.

Ruizhi Wang

CEO Abselion

Get Amperia Now

Experience how Amperia can accelerate your workflow in your own labs. Contact us to learn more or schedule a free product demo.

Contact us
Amperia instrument